GLB1 and GM1 gangliosidosis: The most recent β-gal mutant mouse generated using CRISPR/Cas9 is a knock-in model that introduces a human missense mutation in exon 14 of Glb1, described in a patient with late-infantile GM1 gangliosidosis (Liu et al., 2021).